Ph. Lin et al., Dose-specific production of chlorinated quinone and semiquinone adducts inrodent livers following administration of pentachlorophenol, TOXICOL SCI, 47(1), 1999, pp. 126-133
Production of chlorinated quinoid metabolites was investigated in the liver
s of Sprague-Dawley rats and B6C3F(1) mice following single oral administra
tion of pentachlorophenol (PCP) (0-40 mg/kg body weight) and in male Fische
r 344 rats, following chronic ingestion of PCP at 1,000 ppm in the diet for
6 months (equivalent to 60 mg PCP/kg body weight/day). Analyses of the rat
es of adduction in the livers of Sprague-Dawley rats and B6C3F(1) mice sugg
ested that the production of tetrachloro-1,2-benzosemiquinone (Cl-4-1,2-SQ)
adducts was proportionally greater at low doses of PCP (less than 4-10 mg/
kg body weight) and was 40-fold greater in rats than in mice. Production of
tetrachloro-1,4-benzoquinone (Cl-4-1,4-BQ) adducts, on the other hand, was
proportionally greater at high doses of PCP [greater than 60-230 mg/kg bod
y weight] and was 2- to 11-fold greater in mice than in rats over the entir
e range of dosages. A mathematical model employed these data to predict the
rates of daily adduct production and steady state levels of PCP-derived qu
inone and semiquinone adducts in rats and mice. To evaluate predictions of
the model, levels of PCP-derived adducts at steady state were investigated
in the livers of male Fischer 344 rats chronically ingesting 60 mg PCP/kg b
ody weight/day. Levels of total Cl-4-1,4-BQ-derived adducts in liver cytoso
lic proteins (Cp) (22.0 nmol/g) and in liver nuclear proteins (Np) (3.07 nm
ol/g) were comparable to those of model predictions (15.0 and 3.02 nmol/g f
or Cp and Np, respectively). Overall, these results suggest that species di
fferences in the metabolism of PCP to semiquinones and quinones were, in pa
rt, responsible for the production of liver tumors in mice but not rats in
chronic bioassays.